glp-1 compounding crackdown news october 2025 Compounded GLP-1s are entering a new phase of scrutiny. With the FDA targeting large-scale compounded manufacturing, patients are facing a moment where access, safety, and regulatory clarity all matter. In my Why the FDA is cracking
Description
8 weight loss clinics prescribing GLP-1 medications in Pittsburgh accept health insurance
Alongside, Novo Nordisk agreed to take over Catalents fill-finish plants in Italy, Belgium, and Indiana for $11B ( [10] )
Key Takeaways Retatrutide is an investigational weight-loss drug showing strong results in trials, but it is not FDA-approved yet
Primarily used for type 2 diabetes and obesity, they improve blood sugar control, reduce appetite, and can promote weight loss
What if I dont have diabetes and Im taking a GLP-1 for weight loss
It helps the judge better understand the core issues of the litigation
